Transcriptional regulation by RUNX3
Ebihara T, Song C, Ryu SH, Plougastel-Douglas B, Yang L, Levanon D, Groner Y, Bern MD, Stappenbeck TS, Colonna M, Egawa T, Yokoyama WM. Runx3 specifies lineage commitment of innate lymphoid cells. Nat Immunol. 2015 Nov;16(11):1124–33. PMID: 26414766; PMCID: PMC4618046.; Qiao Y, Lin SJ, Chen Y, Voon DC, Zhu F, Chuang LS, Wang T, Tan P, Lee SC, Yeoh KG, Sudol M, Ito Y. RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer. Oncogene. 2016 May 19;35(20):2664–74. doi: 10.1038/onc.2015.338. PMID: 26364597.; Ogihara Y, Masuda T, Ozaki S, Yoshikawa M, Shiga T. Runx3-regulated expression of two Ntrk3 transcript variants in dorsal root ganglion neurons. Developmental Neurobiology. 2015 Jun 18;76(3):313–22. doi: 10.1002/dneu.22316.; Whittle MC, Izeradjene K, Rani PG, Feng L, Carlson MA, DelGiorno KE, Wood LD, Goggins M, Hruban RH, Chang AE, Calses P, Thorsen SM, Hingorani SR. RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. Cell. 2015 Jun 04;161(6):1345–60. PMID: 26004068; PMCID: PMC4458240.; Luckey MA, Kimura MY, Waickman AT, Feigenbaum L, Singer A, Park JH. The transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing the SOCS suppressors of cytokine signaling. Nat Immunol. 2014 Jul;15(7):638–45. PMID: 24880459; PMCID: PMC6693509.; Reis BS, Rogoz A, Costa-Pinto FA, Taniuchi I, Mucida D. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4? T cell immunity. Nat Immunol. 2013 Mar;14(3):271–80. PMID: 23334789; PMCID: PMC3804366.; Dykes IM, Tempest L, Lee S-, Turner EE. Brn3a and Islet1 Act Epistatically to Regulate the Gene Expression Program of Sensory Differentiation. Journal of Neuroscience. 2011 Jul 06;31(27):9789–99. doi: 10.1523/jneurosci.0901-11.2011.; Huang B, Qu Z, Ong CW, Tsang YH, Xiao G, Shapiro D, Salto-Tellez M, Ito K, Ito Y, Chen LF. RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor a. Oncogene. 2012 Jan 26;31(4):527–34. PMID: 21706051; PMCID: PMC3697905.; Nishina S, Shiraha H, Nakanishi Y, Tanaka S, Matsubara M, Takaoka N, Uemura M, Horiguchi S, Kataoka J, Iwamuro M, Yagi T, Yamamoto K. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling. Oncol Rep. 2011 Sep;26(3):523–31. doi: 10.3892/or.2011.1336. PMID: 21637926.; Levkovitz L, Yosef N, Gershengorn MC, Ruppin E, Sharan R, Oron Y. A Novel HMM-Based Method for Detecting Enriched Transcription Factor Binding Sites Reveals RUNX3 as a Potential Target in Pancreatic Cancer Biology. PLoS ONE. 2010 Dec 22;5(12):e14423. doi: 10.1371/journal.pone.0014423.; Puig-Kröger A, Aguilera-Montilla N, Martínez-Nuñez R, Domínguez-Soto A, Sánchez-Cabo F, Martín-Gayo E, Zaballos A, Toribio ML, Groner Y, Ito Y, Dopazo A, Corcuera MT, Alonso Martín MJ, Vega MA, Corbí AL. The novel RUNX3/p33 isoform is induced upon monocyte-derived dendritic cell maturation and downregulates IL-8 expression. Immunobiology. 2010 Sep;215(9-10):812–20. doi: 10.1016/j.imbio.2010.05.018. PMID: 20615577.; Gao J, Chen Y, Wu KC, Liu J, Zhao YQ, Pan YL, Du R, Zheng GR, Xiong YM, Xu HL, Fan DM. RUNX3 directly interacts with intracellular domain of Notch1 and suppresses Notch signaling in hepatocellular carcinoma cells. Exp Cell Res. 2010 Jan 15;316(2):149–57. doi: 10.1016/j.yexcr.2009.09.025. PMID: 19800882.; Arman M, Aguilera-Montilla N, Mas V, Puig-Kröger A, Pignatelli M, Guigó R, Corbí AL, Lozano F. The human CD6 gene is transcriptionally regulated by RUNX and Ets transcription factors in T cells. Mol Immunol. 2009 Jul;46(11-12):2226–35. doi: 10.1016/j.molimm.2009.04.018. PMID: 19446338.; Wolff EM, Liang G, Cortez CC, Tsai YC, Castelao JE, Cortessis VK, Tsao-Wei DD, Groshen S, Jones PA. RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. Cancer Res. 2008 Aug 01;68(15):6208–14. PMID: 18676844; PMCID: PMC2536768.; Nakamura S, Senzaki K, Yoshikawa M, Nishimura M, Inoue K, Ito Y, Ozaki S, Shiga T. Dynamic regulation of the expression of neurotrophin receptors by Runx3. Development. 2008 May;135(9):1703–11. doi: 10.1242/dev.015248. PMID: 18385258.; Landry JR, Kinston S, Knezevic K, de Bruijn MF, Wilson N, Nottingham WT, Peitz M, Edenhofer F, Pimanda JE, Ottersbach K, Göttgens B. Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver. Blood. 2008 Mar 15;111(6):3005–14. doi: 10.1182/blood-2007-07-098830. PMID: 18184866.; Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito K, Inoue M, Putti TC, Loh M, Ko TK, Huang C, Bhalla KN, Zhu T, Ito Y, Sukumar S. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res. 2006 Jul 01;66(13):6512–20. doi: 10.1158/0008-5472.can-06-0369. PMID: 16818622.; Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006 Jul;38(7):787–93. doi: 10.1038/ng1834. PMID: 16804544.; Kramer I, Sigrist M, de Nooij JC, Taniuchi I, Jessell TM, Arber S. A role for Runx transcription factor signaling in dorsal root ganglion sensory neuron diversification. Neuron. 2006 Feb 02;49(3):379–93. doi: 10.1016/j.neuron.2006.01.008. PMID: 16446142.; Chi X, Yang J, Lee K, Ito K, Sakakura C, Li Q, Kim H, Cha E, Lee Y, Kaneda A, Ushijima T, Kim W, Ito Y, Bae S. RUNX3 Suppresses Gastric Epithelial Cell Growth by Inducing p21WAF1/Cip1 Expression in Cooperation with Transforming Growth Factor ß-Activated SMAD. Molecular and Cellular Biology. 2005 Sep 01;25(18):8097–107. doi: 10.1128/mcb.25.18.8097-8107.2005.; Domínguez-Soto A, Relloso M, Vega MA, Corbí AL, Puig-Kröger A. RUNX3 regulates the activity of the CD11a and CD49d integrin gene promoters. Immunobiology. 2005;210(2-4):133–9. doi: 10.1016/j.imbio.2005.05.008. PMID: 16164020.; Schulmann K, Sterian A, Berki A, Yin J, Sato F, Xu Y, Olaru A, Wang S, Mori Y, Deacu E, Hamilton J, Kan T, Krasna MJ, Beer DG, Pepe MS, Abraham JM, Feng Z, Schmiegel W, Greenwald BD, Meltzer SJ. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene. 2005 Jun 09;24(25):4138–48. doi: 10.1038/sj.onc.1208598. PMID: 15824739.; Dhillon VS, Shahid M, Husain SA. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin. Molecular Cancer. 2004 Dec 01;3(1):33. doi: 10.1186/1476-4598-3-33.; Fainaru O, Woolf E, Lotem J, Yarmus M, Brenner O, Goldenberg D, Negreanu V, Bernstein Y, Levanon D, Jung S, Groner Y. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 2004 Feb 25;23(4):969–79. PMID: 14765120; PMCID: PMC380997.; Inoue K, Ozaki S, Shiga T, Ito K, Masuda T, Okado N, Iseda T, Kawaguchi S, Ogawa M, Bae SC, Yamashita N, Itohara S, Kudo N, Ito Y. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci. 2002 Oct;5(10):946–54. doi: 10.1038/nn925. PMID: 12352981.; Li QL, Ito K, Sakakura C, Fukamachi H, Inoue Ki, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 2002 Apr 05;109(1):113–24. doi: 10.1016/s0092-8674(02)00690-6. PMID: 11955451.